New insider activity at Voyager Therapeutics ( (VYGR) ) has taken place on October 7, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
CFO Nathan D. Jorgensen recently sold 7,666 shares of Voyager Therapeutics stock, amounting to a total transaction value of $36,643.
Spark’s Take on VYGR Stock
According to Spark, TipRanks’ AI Analyst, VYGR is a Neutral.
Voyager Therapeutics’ overall stock score is primarily influenced by its financial performance challenges, including negative profit margins and fluctuating cash flows. However, positive technical indicators and strategic corporate events provide some optimism. The valuation remains a concern due to ongoing losses, but the company’s participation in industry conferences and strategic advancements offer potential for future growth.
To see Spark’s full report on VYGR stock, click here.
More about Voyager Therapeutics
YTD Price Performance: -17.09%
Average Trading Volume: 757,424
Technical Sentiment Signal: Hold
Current Market Cap: $274.6M